Polaryx Therapeutics, Inc. (PLYX) — Dilution Risk Analysis
Current Snapshot
Polaryx Therapeutics, Inc. (PLYX) has a DilutionWatch score of 47/10 and is classified as MEDIUM risk. The score date in the source data is 2026-09-08T03:43:49.189997.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 47/10 Source (as of 2026-09-08T03:43:49.189997)
Recent SEC Filings
Recent filing forms in the source payload: 8-K 1, 4 1.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-05-28 | 0001213900-26-062155 |
| 4 | 2026-05-28 | 0001213900-26-062322 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 35 months | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 47/10) Source
- Cash Runway
- 35 months Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.